⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EQ News
Equillium, Inc. Common Stock
Equillium to Participate in Upcoming Investor Conferences
globenewswire.com
EQ
Form 8-K
sec.gov
EQ
Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504
globenewswire.com
EQ
Equiniti’s Market Engagement Business Unites Corporate and Fund Proxy Under the D.F. King Brand, Adding Notified Investor Engagement Capabilities to Every Campaign
globenewswire.com
EQ
Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference
globenewswire.com
EQ
Form 8-K
sec.gov
EQ
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
globenewswire.com
EQ
Equillium Announces Poster Presentations at the 7th International AHR Conference
globenewswire.com
EQ
Integrated Rewards Launches "Celebrate Canadian" Campaign to Connect Canadian Brands with Millions of Consumers
accessnewswire.com
EQ
Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum
globenewswire.com
EQ